Table 4 FMD, NMD and IMT in MCTD patients with/without cardiovascular disease and controls
| Â | %FMDa | Pvalue | %NMDa | Pvalue | IMTa | Pvalue |
|---|---|---|---|---|---|---|
Age at investigation (years) | -0.0221 | 0.878 | -0.6700 | 0.001 | 0.5468 | 0.001 |
Disease duration (years) | -0.6468 | 0.001 | -0.1314 | 0.3628 | 0.1968 | 0.1706 |
Systolic blood pressure (mmHg) | -0.5423 | 0.001 | -0.1094 | 0.4492 | 0.2220 | 0.1211 |
Diastolic blood pressure (mmHg) | 0.0946 | 0.5133 | 0.1005 | 0.4872 | -0.1597 | 0.2676 |
Serum triglycerides (mmol/l) | -0.3396 | 0.0158 | 0.2165 | 0.1309 | -0.0411 | 0.7765 |
Serum cholesterol | -0.0459 | 0.7514 | 0.0508 | 0.7255 | -0.0209 | 0.8851 |
Apolipoprotein A1 (g/l) | 0.6203 | 0.001 | -0.0805 | 0.5782 | -0.0248 | 0.8640 |
Apolipoprotein B (g/l) | -0.3102 | 0.061 | -0.0891 | 0.5997 | 0.0767 | 0.6517 |
Paraoxonase-1 activity | 0.5957 | 0.001 | 0.1317 | 0.3619 | -0.2789 | 0.0497 |
hs-CRP | -0.4057 | 0.003 | -0.3207 | 0.023 | 0.7164 | 0.001 |
ESR | -0.4283 | 0.001 | -0.3981 | 0.001 | 0.5467 | 0.001 |
Anti-U1RNP (U/ml) | -0.0486 | 0.7371 | -0.0694 | 0.6316 | 0.4182 | 0.0025 |
Anti-CL IgG (U/ml) | -0.0717 | 0.6206 | -0.0411 | 0.776 | 0.2236 | 0.1184 |
AECA (IU/ml) | -0.3075 | 0.029 | -0.2686 | 0.0592 | 0.2890 | 0.0417 |
Thrombomodulin (ng/ml) | -0.0642 | 0.6577 | -0.0165 | 0.9089 | 0.4823 | 0.00038 |
vWFAg (%) | -0.0122 | 0.9329 | -0.2692 | 0.058 | 0.5443 | 0.001 |